| Literature DB >> 26155160 |
Hossam Ebaid1, Iftekhar Hassan2, Samir Bashandy3, Nael Abu Taha2, Amer Mahmood4, Suliman Alomar2, Iibrahim Alhazza2, Ashraf Mashaly1, Ahmed Rady2.
Abstract
The effects of Cadmium (Cd) exposure and the treatment with Zinc (Zn) on immune functions of splenocytes and cultured lymphocytes of rats were studied. The exposure of rats to Cd was at a dose of 2.2 mg/kg CdCl2, injected subcutaneously four times weekly for 2 months. Rats were supplemented with Zn (2.2 mg/kg ZnCl2, injected subcutaneously four times weekly for 2 months) one hour prior to Cd exposure. Spleens were removed and splenocytes were isolated and cultured. The proliferation capacity of lymphocytes and their homing to the spleen were studied. Ribonucleic acid (RNA) was extracted from stimulated lymphocytes in order to analyse gene expressions using RT-PCR. Accordingly, proliferation of lymphocytes was found to be suppressed in Cd-treated rats, both in vivo and in vitro. Zinc served to activate the proliferation of B and T lymphocytes in Cd-treated rats both in vivo and in vitro. Antigen-activated lymphocytes showed that Cd impaired the mRNA expression of CD68, Ccl22 and CXCL10. Zinc was not found to restore mRNA expression of these genes to the normal levels. Zinc was found to decrease the MDA level with replenishment of activity of key antioxidant enzymes and proteins in Cd-pre-treated animals significantly. Moreover, the histopathological examination of spleen samples also agreed with the molecular, immunological and redox findings. Hence, Zn is able to restore the normal structure, redox status and immunity in Cd-induced damage in the rat model system.Entities:
Keywords: Cadmium; Zinc; chemokines; lymphocyte subsets; oxidative stress
Year: 2014 PMID: 26155160 PMCID: PMC4439953 DOI: 10.5114/ceji.2014.47726
Source DB: PubMed Journal: Cent Eur J Immunol ISSN: 1426-3912 Impact factor: 2.085
List of primers used to amplify the desired genes
| Primer name | Primer length | ||
|---|---|---|---|
| CD68 | Forward | GGACCCACAACTGTCACTCAT | 21 |
| Reverse | AAGCCCCACTTTAGCTTTACC | 21 | |
| Ccl-22 | Forward | AGGTCCCTATGGTGCCAATGT | 21 |
| Reverse | CGGCAGGATTTTGAGGTCCA | 20 | |
| CXCL-10 | Forward | CCAAGTGCTGCCGTCATTTTC | 21 |
| Reverse | GGCTCGCAGGGATGATTTCAA | 21 |
Fig. 1Effect of the treatment on the level of reduced glutathione (GSH) (A), the major antioxidant enzymes CAT (B), SOD (C) and the level of lipid peroxidation (MDA) (D) in spleen samples. *shows the significance (p < 0.05) in comparison to the control group. #shows the significance (p < 0.05) in comparison to the Cd-treated group
Fig. 2A) Relative spleen weight from different groups showing the significant higher spleen relative weight of Cd rats in comparison to the control and other groups. Zn was found to significantly restore the spleen relative weight in Cd + Zn rats. B) MTT assay for the cell viability percentage of splenocytes from the four different groups. Values are the mean ± SD. *shows the significance (p < 0.05) in comparison to the control group. #shows the significance (p < 0.05) in comparison to the Cd-treated group
Fig. 3Representative spleen sections stained with H&E from control (A) Cd + Zn (B), (C), and Zn (D) groups (200×)
Fig. 4Spleen sections stained with anti-CD3+ antibodies to realize T cells from control (A),Cd + Zn (B), Cd (C) and Zn (D) groups (200×)
Fig. 5Spleen sections stained with anti-CD20+ antibodies to realize B cells from control (A), Cd + Zn (B), Cd (C) and Zn (D) groups (200×)
Fig. 6RT-PCR mRNA expression of CD68, Ccl22 and CXCL10 (A) of the antigen activated lymphocytes from different groups. B) The relative intensity of CD68 bands. C) The relative intensity of Ccl22 bands. D) The relative intensity of CXCL10 bands. PCR products were separated and visualized by DNA agarose electrophoresis after amplification of CD68, Ccl22 and CXCL10 from splenocyte genomic DNA. Values are the mean ± SD. *shows the significance (p < 0.05) in comparison to the control group (Co). #shows the significance (p < 0.05) in comparison to the Cd-treated group